US Patent 8563517 Dipeptidyl peptidase IV (DP-IV) compounds
Patent 8563517 was granted and assigned to Cadila Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08563517 Dipeptidyl peptidase IV (DP-IV) compounds US Patent 8563517 Dipeptidyl peptidase IV (DP-IV) compounds
Infobox
Patent Number
0856351700
Patent Number
856351700
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085635170
Date of Patent
October 22, 2013
0Patent Application Number
130636910
Date Filed
September 11, 2009
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085635170
Date of Patent
October 22, 2013
0Patent Application Number
130636910
Date Filed
September 11, 2009
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08563517 Dipeptidyl peptidase IV (DP-IV) compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08563517
Date of patent
October 22, 2013
Patent application number
13063691
Date Filed
September 11, 2009
Patent primary examiner
Find more entities like US Patent 8563517 Dipeptidyl peptidase IV (DP-IV) compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.